ANDOVER, Mass., Dec. 7 /PRNewswire-FirstCall/ -- Smith & Nephew's (NYSE: SNN;LSE:SN) Endoscopy Division today announced the appointment of Todd Usen as its Senior Vice President of US Sales.
Usen joins Smith & Nephew Endoscopy with more than 20 years experience in the medical device industry, the last 12 at Boston Scientific where he helped build high performing sales teams. Over the last decade, he has served in many leadership roles, most recently as Vice President of Domestic (US) Sales for Boston Scientific's $350 million Neurovascular Division.
He started his career in sales with Kendall Healthcare before moving to Arrow International. He holds a bachelor's degree from the University of Massachusetts and is pursuing an MBA from Pepperdine University.
"Throughout Todd's career he has developed a reputation for
successfully motivating and managing sales teams and delivering results,"
said Mike Frazzette, President, Smith & Nephew Endoscopy. "I look forward
to Todd's bringing that same skill set to Endoscopy and contributing to our
continued leadership in the arthroscopy marketplace."
Contact: Joe Metzger
Vice President, Corporate Communications
Smith & Nephew Endoscopy
Smith & Nephew is a global medical technology business, specialising in Orthopaedic Reconstruction, Orthopaedic Trauma and Clinical Therapies, Endoscopy and Advanced Wound Management products. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2006 were nearly $2.8 billion.
This press release contains certain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. In particular, statements regarding planned growth in our business and in our operating margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward- looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.
All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
|SOURCE Smith & Nephew|
Copyright©2007 PR Newswire.
All rights reserved